CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: coccidiostat
Accession: CHEBI:35818
browse the term
Definition: An agent useful in the treatment or prevention of coccidiosis in man or animals.
Synonyms: related_synonym: anticoccidial agent; coccidiostats
G
Slc19a3
solute carrier family 19 member 3
multiple interactions
ISO
Amprolium inhibits the reaction [SLC19A3 protein results in increased uptake of Metformin]; Amprolium inhibits the reaction [SLC19A3 protein results in increased uptake of Thiamine]
CTD
PMID:26528626
NCBI chr 9:84,275,722...84,299,368
Ensembl chr 9:84,277,024...84,299,337
G
Abcb1a
ATP binding cassette subfamily B member 1A
decreases expression increases transport
ISO
antibiotic G 418 results in decreased expression of ABCB1 mRNA ABCB1 protein results in increased transport of antibiotic G 418
CTD
PMID:20018165
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
G
Abcc1
ATP binding cassette subfamily C member 1
increases transport
ISO
ABCC1 protein results in increased transport of antibiotic G 418
CTD
PMID:20018165
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
G
Abcc2
ATP binding cassette subfamily C member 2
increases transport
ISO
ABCC2 protein results in increased transport of antibiotic G 418
CTD
PMID:20018165
NCBI chr 1:242,664,657...242,723,239
Ensembl chr 1:242,664,657...242,723,238
G
Abcc3
ATP binding cassette subfamily C member 3
increases transport
ISO
ABCC3 protein results in increased transport of antibiotic G 418
CTD
PMID:20018165
NCBI chr10:79,296,681...79,342,749
Ensembl chr10:79,296,693...79,342,595
G
Atm
ATM serine/threonine kinase
increases expression
ISO
antibiotic G 418 results in increased expression of ATM protein mutant form
CTD
PMID:15498871
NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
G
Avpr2
arginine vasopressin receptor 2
multiple interactions
ISO
antibiotic G 418 results in increased expression of and results in increased activity of AVPR2 protein mutant form
CTD
PMID:12414899 PMID:14998935
NCBI chr X:151,633,501...151,636,155
Ensembl chr X:151,633,522...151,635,989
G
Capn2
calpain 2
increases cleavage
ISO
antibiotic G 418 results in increased cleavage of CAPN2 protein
CTD
PMID:15241557
NCBI chr13:94,150,244...94,200,969
Ensembl chr13:94,150,240...94,200,969
G
Casp12
caspase 12
increases cleavage
ISO
antibiotic G 418 results in increased cleavage of CASP12 protein
CTD
PMID:15241557
NCBI chr 8:2,642,296...2,669,549
Ensembl chr 8:2,642,434...2,674,037
G
Casp3
caspase 3
increases activity
ISO
antibiotic G 418 results in increased activity of CASP3 protein
CTD
PMID:15241557
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
increases activity multiple interactions
ISO
antibiotic G 418 results in increased activity of CASP9 protein benzyloxycarbonyl-leucyl-glutamyl-histidyl-aspartic acid fluoromethyl ketone inhibits the reaction [antibiotic G 418 results in increased activity of CASP9 protein]
CTD
PMID:15241557
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cftr
CF transmembrane conductance regulator
increases expression
ISO
antibiotic G 418 results in increased expression of CFTR protein mutant form
CTD
PMID:17541014
NCBI chr 4:46,561,269...46,728,759
Ensembl chr 4:46,560,885...46,728,756
G
F7
coagulation factor VII
multiple interactions
ISO
antibiotic G 418 results in increased expression of and results in increased activity of F7 protein
CTD
PMID:16706976
NCBI chr16:76,489,775...76,500,636
Ensembl chr16:76,489,717...76,500,610
G
Gpx1
glutathione peroxidase 1
affects localization
ISO
antibiotic G 418 affects the localization of GPX1 mRNA mutant form
CTD
PMID:28743738
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
G
Hsf1
heat shock transcription factor 1
increases activity
ISO
antibiotic G 418 results in increased activity of HSF1 protein
CTD
PMID:34170685
NCBI chr 7:108,196,040...108,223,011
Ensembl chr 7:108,196,056...108,223,011
G
Kcnj1
potassium inwardly-rectifying channel, subfamily J, member 1
increases expression
ISO
antibiotic G 418 results in increased expression of KCNJ1 protein mutant form
CTD
PMID:12911542
NCBI chr 8:30,779,883...30,808,607
Ensembl chr 8:30,753,617...30,813,796
G
Mmut
methylmalonyl-CoA mutase
affects expression multiple interactions
ISO
antibiotic G 418 affects the expression of MMUT mRNA mutant form [antibiotic G 418 co-treated with Gentamicins] affects the activity of MMUT protein mutant form; [antibiotic G 418 co-treated with Gentamicins] affects the expression of MMUT mRNA mutant form; antibiotic G 418 promotes the reaction [Gentamicins affects the expression of MMUT protein mutant form]
CTD
PMID:19427250
NCBI chr 9:19,928,720...19,956,985
Ensembl chr 9:19,928,727...19,957,046
G
Slc4a4
solute carrier family 4 member 4
increases expression
ISO
antibiotic G 418 results in increased expression of SLC4A4 protein mutant form
CTD
PMID:18614622
NCBI chr14:18,841,289...19,293,297
Ensembl chr14:18,845,159...19,272,883
G
Upf1
UPF1, RNA helicase and ATPase
affects localization
ISO
antibiotic G 418 affects the localization of UPF1 protein
CTD
PMID:28743738
NCBI chr16:19,076,594...19,097,365
Ensembl chr16:19,076,322...19,096,568
G
Actb
actin, beta
increases expression
ISO
Lasalocid results in increased expression of ACTB protein
CTD
PMID:37788135
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
G
Anxa1
annexin A1
increases expression
ISO
Lasalocid results in increased expression of ANXA1 protein
CTD
PMID:37788135
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa2
annexin A2
increases expression
ISO
Lasalocid results in increased expression of ANXA2 protein
CTD
PMID:37788135
NCBI chr 8:70,105,268...70,141,663
Ensembl chr 8:70,105,253...70,141,658
G
Dsp
desmoplakin
increases expression
ISO
Lasalocid results in increased expression of DSP protein
CTD
PMID:37788135
NCBI chr17:26,623,602...26,671,692
Ensembl chr17:26,623,588...26,671,800
G
Hnrnpa1
heterogeneous nuclear ribonucleoprotein A1
increases expression
ISO
Lasalocid results in increased expression of HNRNPA1 protein
CTD
PMID:37788135
NCBI chr 7:134,375,318...134,381,610
Ensembl chr 7:134,375,150...134,381,609
G
Hnrnpa2b1
heterogeneous nuclear ribonucleoprotein A2/B1
increases expression
ISO
Lasalocid results in increased expression of HNRNPA2B1 protein
CTD
PMID:37788135
NCBI chr 4:80,534,659...80,545,297
Ensembl chr 4:80,534,651...80,545,249
G
Hspb1
heat shock protein family B (small) member 1
increases expression
ISO
Lasalocid results in increased expression of HSPB1 protein
CTD
PMID:37788135
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
G
Ivl
involucrin
increases expression
ISO
Lasalocid results in increased expression of IVL protein
CTD
PMID:37788135
NCBI chr 2:178,146,694...178,160,807
Ensembl chr 2:178,147,061...178,149,100
G
Jup
junction plakoglobin
increases expression
ISO
Lasalocid results in increased expression of JUP protein
CTD
PMID:37788135
NCBI chr10:85,300,438...85,327,378
Ensembl chr10:85,300,440...85,327,057
G
Krt5
keratin 5
increases expression
ISO
Lasalocid results in increased expression of KRT5 protein
CTD
PMID:37788135
NCBI chr 7:132,846,132...132,851,861
Ensembl chr 7:132,846,136...132,851,850
G
Mapt
microtubule-associated protein tau
decreases expression
ISO
Lasalocid results in decreased expression of MAPT protein
CTD
PMID:16930453
NCBI chr10:89,138,644...89,236,137
Ensembl chr10:89,138,627...89,236,129
G
Pkp1
plakophilin 1
increases expression
ISO
Lasalocid results in increased expression of PKP1 protein
CTD
PMID:37788135
NCBI chr13:47,309,607...47,357,432
Ensembl chr13:47,309,614...47,357,465
G
Ppl
periplakin
increases expression
ISO
Lasalocid results in increased expression of PPL protein
CTD
PMID:37788135
NCBI chr10:10,450,919...10,496,575
Ensembl chr10:10,450,919...10,496,575
G
S100a10
S100 calcium binding protein A10
increases expression
ISO
Lasalocid results in increased expression of S100A10 protein
CTD
PMID:37788135
NCBI chr 2:179,221,012...179,229,659
Ensembl chr 2:179,220,887...179,229,661
G
S100a11
S100 calcium binding protein A11
increases expression
ISO
Lasalocid results in increased expression of S100A11 protein
CTD
PMID:37788135
NCBI chr 2:179,191,688...179,197,098
Ensembl chr 2:179,191,715...179,197,044
G
S100a16
S100 calcium binding protein A16
increases expression
ISO
Lasalocid results in increased expression of S100A16 protein
CTD
PMID:37788135
NCBI chr 2:176,016,405...176,022,117
Ensembl chr 2:176,016,268...176,022,117
G
Serpinb2
serpin family B member 2
increases expression
ISO
Lasalocid results in increased expression of SERPINB2 protein
CTD
PMID:37788135
NCBI chr13:23,537,312...23,551,823
Ensembl chr13:23,541,400...23,550,408
G
Sprr1a
small proline-rich protein 1A
increases expression
ISO
Lasalocid results in increased expression of SPRR1A protein
CTD
PMID:37788135
NCBI chr 2:178,055,096...178,057,012
Ensembl chr 2:178,055,096...178,057,063
G
Sprr1b
small proline-rich protein 1B
increases expression
ISO
Lasalocid results in increased expression of SPRR1B protein
CTD
PMID:37788135
NCBI chr 2:178,008,844...178,010,742
Ensembl chr 2:178,009,130...178,009,567
G
Sprr2d
small proline-rich protein 2D
increases expression
ISO
Lasalocid results in increased expression of SPRR2D protein
CTD
PMID:37788135
NCBI chr 2:177,870,082...177,870,679
Ensembl chr 2:177,870,434...177,870,679
G
App
amyloid beta precursor protein
multiple interactions
ISO
Monensin inhibits the reaction [[Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-40)]; Monensin inhibits the reaction [[Ketamine results in increased cleavage of APP protein] which results in increased abundance of amyloid beta-protein (1-42)] Monensin inhibits the reaction [Ketamine results in decreased expression of and results in increased cleavage of APP protein]
CTD
PMID:35378374
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Atp7a
ATPase copper transporting alpha
multiple interactions
ISO
Monensin inhibits the reaction [ATP7A protein affects the localization of Doxorubicin]
CTD
PMID:17510416
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Bace1
beta-secretase 1
multiple interactions
ISO
Monensin inhibits the reaction [Ketamine results in increased expression of and affects the localization of BACE1 protein]
CTD
PMID:35378374
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
G
Bnip3
BCL2 interacting protein 3
increases expression
ISO
Monensin results in increased expression of BNIP3 protein
CTD
PMID:30718715
NCBI chr 1:193,708,164...193,725,348
Ensembl chr 1:193,708,167...193,725,359
G
Casp3
caspase 3
multiple interactions increases activity
ISO
Lithium inhibits the reaction [Monensin results in increased activity of CASP3 protein]
CTD
PMID:20799912
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp7
caspase 7
multiple interactions increases activity
ISO
Lithium inhibits the reaction [Monensin results in increased activity of CASP7 protein]
CTD
PMID:20799912
NCBI chr 1:255,437,438...255,476,737
Ensembl chr 1:255,437,172...255,476,729
G
Csf2
colony stimulating factor 2
multiple interactions
ISO
Monensin inhibits the reaction [kaempferol results in increased secretion of CSF2 protein]; Monensin inhibits the reaction [Quercetin results in increased secretion of CSF2 protein]
CTD
PMID:18346843
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Egf
epidermal growth factor
multiple interactions
EXP
[EGF protein co-treated with Monensin] results in increased expression of MYC mRNA
CTD
PMID:12632255
NCBI chr 2:218,219,408...218,302,359
Ensembl chr 2:218,219,415...218,302,064
G
Il6
interleukin 6
decreases secretion
ISO
Monensin results in decreased secretion of IL6 protein
CTD
PMID:11216681
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Ins1
insulin 1
decreases degradation
EXP
Monensin results in decreased degradation of INS1 protein
CTD
PMID:2645939
NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
G
Myc
MYC proto-oncogene, bHLH transcription factor
multiple interactions
EXP
[EGF protein co-treated with Monensin] results in increased expression of MYC mRNA
CTD
PMID:12632255
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
Monensin results in increased cleavage of PARP1 protein
CTD
PMID:30718715
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Slc6a2
solute carrier family 6 member 2
multiple interactions
ISO
Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]]
CTD
PMID:29908239
NCBI chr19:14,010,292...14,055,317
Ensembl chr19:14,010,386...14,050,357
G
Slc6a3
solute carrier family 6 member 3
multiple interactions
ISO
Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium]]
CTD
PMID:29908239
NCBI chr 1:29,709,443...29,750,413
Ensembl chr 1:29,709,443...29,750,413
G
Slc6a4
solute carrier family 6 member 4
multiple interactions
ISO
Monensin promotes the reaction [para-methyl-4-methylaminorex inhibits the reaction [SLC6A4 protein results in increased uptake of Serotonin]]
CTD
PMID:29908239
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
G
Trpm2
transient receptor potential cation channel, subfamily M, member 2
decreases expression increases expression multiple interactions
ISO
Monensin results in decreased expression of TRPM2 protein alternative form Monensin results in increased expression of TRPM2 protein alternative form Lithium inhibits the reaction [Monensin results in increased expression of TRPM2 protein alternative form]
CTD
PMID:20799912
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
G
Zeb1
zinc finger E-box binding homeobox 1
increases response to substance
ISO
ZEB1 protein results in increased susceptibility to Monensin
CTD
PMID:30718715
NCBI chr17:51,948,948...52,116,018
Ensembl chr17:51,948,948...52,115,214
G
Angpt1
angiopoietin 1
decreases expression
ISO
Roxarsone results in decreased expression of ANGPT1 mRNA
CTD
PMID:18414637
NCBI chr 7:73,528,345...73,783,953
Ensembl chr 7:73,531,486...73,784,067
G
Cnmd
chondromodulin
decreases expression
ISO
Roxarsone results in decreased expression of CNMD mRNA
CTD
PMID:18414637
NCBI chr15:55,041,548...55,066,297
Ensembl chr15:55,041,561...55,066,297
G
Cxcl9
C-X-C motif chemokine ligand 9
decreases expression
ISO
Roxarsone results in decreased expression of CXCL9 mRNA
CTD
PMID:18414637
NCBI chr14:15,722,868...15,727,779
Ensembl chr14:15,722,908...15,728,435
G
Enpp2
ectonucleotide pyrophosphatase/phosphodiesterase 2
increases secretion
ISO
Roxarsone results in increased secretion of ENPP2 protein
CTD
PMID:22952646
NCBI chr 7:86,202,345...86,325,050
Ensembl chr 7:86,202,350...86,324,827
G
Fhdc1
FH2 domain containing 1
decreases expression
ISO
Roxarsone results in decreased expression of INF1 mRNA
CTD
PMID:18414637
NCBI chr 2:169,790,917...169,829,580
Ensembl chr 2:169,790,947...169,827,896
G
Hgf
hepatocyte growth factor
increases expression
ISO
Roxarsone results in increased expression of HGF mRNA
CTD
PMID:18414637
NCBI chr 4:18,673,736...18,745,582
Ensembl chr 4:18,677,101...18,745,409
G
Lep
leptin
decreases expression
ISO
Roxarsone results in decreased expression of LEP mRNA
CTD
PMID:18414637
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
G
Mmp9
matrix metallopeptidase 9
increases expression
ISO
Roxarsone results in increased expression of MMP9 mRNA; Roxarsone results in increased expression of MMP9 protein
CTD
PMID:22952646
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
G
Mtor
mechanistic target of rapamycin kinase
increases expression multiple interactions
EXP
Roxarsone results in increased expression of MTOR mRNA Roxarsone results in increased expression of and results in increased phosphorylation of MTOR protein; Sirolimus inhibits the reaction [Roxarsone results in increased expression of and results in increased phosphorylation of MTOR protein]
CTD
PMID:35985552
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nos3
nitric oxide synthase 3
multiple interactions
ISO
Roxarsone results in increased phosphorylation of and results in increased activity of NOS3 protein
CTD
PMID:18414637
NCBI chr 4:10,793,834...10,814,170
Ensembl chr 4:10,793,834...10,814,166
G
Pecam1
platelet and endothelial cell adhesion molecule 1
increases expression multiple interactions
ISO
Roxarsone results in increased expression of PECAM1 protein Semaxinib inhibits the reaction [Roxarsone results in increased expression of PECAM1 protein]
CTD
PMID:30028964
NCBI chr10:91,590,521...91,652,279
Ensembl chr10:91,590,521...91,652,116
G
Plg
plasminogen
decreases expression
ISO
Roxarsone results in decreased expression of PLG mRNA
CTD
PMID:18414637
NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
G
Rps6kb1
ribosomal protein S6 kinase B1
multiple interactions increases expression
EXP
Roxarsone results in increased expression of and results in increased phosphorylation of RPS6KB1 protein; Sirolimus inhibits the reaction [Roxarsone results in increased expression of and results in increased phosphorylation of RPS6KB1 protein] Roxarsone results in increased expression of RPS6KB1 mRNA
CTD
PMID:35985552
NCBI chr10:71,323,777...71,367,908
Ensembl chr10:71,323,777...71,367,908
G
Vegfa
vascular endothelial growth factor A
multiple interactions
EXP
Roxarsone results in increased expression of and results in increased secretion of VEGFA protein
CTD
PMID:24035937
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
G
Cyp2c79
cytochrome P450, family 2, subfamily c, polypeptide 79
increases hydroxylation
ISO
CYP2C8 protein results in increased hydroxylation of Sulfadiazine
CTD
PMID:15843491
G
Grin1
glutamate ionotropic receptor NMDA type subunit 1
decreases expression
ISO
Sulfadiazine results in decreased expression of GRIN1 mRNA
CTD
PMID:34748853
NCBI chr 3:8,103,680...8,130,603
Ensembl chr 3:8,103,680...8,130,603
G
Hmbs
hydroxymethylbilane synthase
decreases activity
EXP
Sulfadiazine decreases activity of purified Hmbs protein
RGD
PMID:6893114
RGD:26923963
NCBI chr 8:44,673,554...44,680,950
Ensembl chr 8:44,673,554...44,680,957
G
Il6
interleukin 6
multiple interactions
ISO
[Sulfadiazine co-treated with Pyrimethamine] results in decreased expression of IL6 protein; [Trimethoprim co-treated with Sulfadiazine] results in increased expression of IL6 protein
CTD
PMID:10888991 PMID:37722575
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Lpo
lactoperoxidase
decreases expression
ISO
Sulfadiazine results in decreased expression of LPO mRNA
CTD
PMID:34748853
NCBI chr10:72,606,950...72,626,220
Ensembl chr10:72,606,944...72,626,535
G
Mtor
mechanistic target of rapamycin kinase
decreases expression
ISO
Sulfadiazine results in decreased expression of MTOR mRNA
CTD
PMID:34748853
NCBI chr 5:158,884,856...158,994,311
Ensembl chr 5:158,884,804...158,994,311
G
Nat2
N-acetyltransferase 2
increases acetylation
ISO
NAT2 protein results in increased acetylation of Sulfadiazine
CTD
PMID:15843491
NCBI chr16:22,207,362...22,238,513
Ensembl chr16:22,208,194...22,238,520
G
Olig2
oligodendrocyte transcription factor 2
decreases expression
ISO
Sulfadiazine results in decreased expression of OLIG2 mRNA
CTD
PMID:34748853
NCBI chr11:30,475,510...30,478,886
Ensembl chr11:30,475,398...30,480,152
G
Shank2
SH3 and multiple ankyrin repeat domains 2
decreases expression
ISO
Sulfadiazine results in decreased expression of SHANK2 mRNA
CTD
PMID:34748853
NCBI chr 1:199,146,210...199,590,962
Ensembl chr 1:199,169,429...199,589,394
G
Slc6a4
solute carrier family 6 member 4
decreases expression
ISO
Sulfadiazine results in decreased expression of SLC6A4 mRNA
CTD
PMID:34748853
NCBI chr10:61,824,208...61,858,924
Ensembl chr10:61,826,123...61,858,384
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all